SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Henry Niman who wrote (16968)3/9/1998 5:45:00 PM
From: rocket  Respond to of 32384
 
Thank you, Henry, for all the work you do on this thread. Your cogent analysis of this company and its products are welcome and appreciated by many of us. Karl



To: Henry Niman who wrote (16968)3/9/1998 5:54:00 PM
From: Russian Bear  Read Replies (1) | Respond to of 32384
 
You were right, Henry. (I thought this would be the case.) biz.yahoo.com

On another topic, I have noticed (Herbert mentioned this a short time, and what seems like a few thousand posts, ago) that when one of my buy orders is not filled (or is only filled partially,) the stock in question tends to rise. Contrariwise, when a buy fill is "too easy," the stock tends to decline in the near term. So, for what it is worth, let me share some good (?) news with you: I had a partially (62.5%) filled buy order on LGNDW, today.

Regards,
RB



To: Henry Niman who wrote (16968)3/10/1998 1:52:00 PM
From: tuck  Read Replies (2) | Respond to of 32384
 
Henry,

They would announce that just after I sign off. How interesting. I can understand the Lilly drug not being a SERM, but I was virtually certain they'd picked the compound, albeit fairly recently. I'll get back to y'all on this in a few days.

Thanks for humoring me for a minute. If nothing else, this little subplot will allow me to evaluate my sources.

Regards, Tuck